Stephen K. Brannan, Chief Medical Officer at Karuna Therapeutics, Inc. (KRTX), sold 8,750 shares at $181.50 ($1.6M) on 2023-08-08, disclosed to the SEC on 2023-08-10.
Scheduled sale ($1.6M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $179.53 | 2,395 | $430K | 27.3% |
| 2 | $179.53 | 2,395 | $430K | 27.3% |
| 3 | $180.93 | 1,355 | $245K | 15.5% |
| 4 | $180.93 | 1,355 | $245K | 15.5% |
| 5 | $181.50 | 1,250 | $227K | 14.4% |
| Total | $180.24 avg | 8,750 |
| $1.6M |
| 100% |
| Filing → |
| KRTX | SELL | 2024-02-12 | $3.2M | — | Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |